Arcus biosciences to host conference call to discuss third-quarter 2024 financial results and pipeline update

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced that its management team will host a conference call and webcast on wednesday, november 6th, 2024 at 2 pm pt / 5 pm et to discuss details of the company's financial results and pipeline update for the quarter ended september 30th, 2024. investors interested in listening to.
RCUS Ratings Summary
RCUS Quant Ranking